Express Pharma (Vol.12, No.18) July 16-31, 2017
India's Foremost Pharma & Biotech Magazine
Author
Lupin recalls 12,480 bottles of anti-depressant drug from US market
The product is used for the treatment of depression, panic disorder and social anxiety disorder
Aurobindo Pharma receives approval for Sevelamer Carbonate tabs
Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis
Maiden biopharma mission Innovate in India (i3) launched
The programme will focus on development of vaccines for diseases like dengue, cervical cancer, bio-therapeutics
Glenmark Pharma in agreement with Cyndea
Under the agreement, Glenmark and Cyndea will partner to develop, license, manufacture and supply for commercialisation generic…
DRL commercialises Vozet tabs in India
Vozet tabs are indicated for the treatment of allergic Rhinitis and chronic Urticaria
Jubilant Life Sciences posts Q1 FY18 consolidated revenue of Rs 1,596 cr
Pharmaceuticals revenue was recorded at Rs 818 crore, contributing 51 per cent to the revenues
ICICI Securities posts preview of Q1FY18 result
Expects pharma companies under its coverage to report weak set of results for the quarter ended Jun'17
Indian pharma exports to US may go up in 2017-18: Report
The pharma industry (IPI) earns around 70 per cent of its revenues from sale of generic drugs and generates around 50 per cent of…